The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance
- 24 August 2014
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 32 (9) , 926-932
Abstract
A comparison of RNA-seq and microarray data from samples treated with diverse drugs highlights a dependency of cross-platform concordance on treatment effect. The concordance of RNA-sequencing (RNA-seq) with microarrays for genome-wide analysis of differential gene expression has not been rigorously assessed using a range of chemical treatment conditions. Here we use a comprehensive study design to generate Illumina RNA-seq and Affymetrix microarray data from the same liver samples of rats exposed in triplicate to varying degrees of perturbation by 27 chemicals representing multiple modes of action (MOAs). The cross-platform concordance in terms of differentially expressed genes (DEGs) or enriched pathways is linearly correlated with treatment effect size (R2≈0.8). Furthermore, the concordance is also affected by transcript abundance and biological complexity of the MOA. RNA-seq outperforms microarray (93% versus 75%) in DEG verification as assessed by quantitative PCR, with the gain mainly due to its improved accuracy for low-abundance transcripts. Nonetheless, classifiers to predict MOAs perform similarly when developed using data from either platform. Therefore, the endpoint studied and its biological complexity, transcript abundance and the genomic application are important factors in transcriptomic research and for clinical and regulatory decision making.Keywords
This publication has 44 references indexed in Scilit:
- Dynamic expression of 3′ UTRs revealed by Poisson hidden Markov modeling of RNA-Seq: Implications in gene expression profilingGene, 2013
- RNA-Seq Profiling Reveals Novel Hepatic Gene Expression Pattern in Aflatoxin B1 Treated RatsPLOS ONE, 2013
- Comparative RNA-Seq and Microarray Analysis of Gene Expression Changes in B-Cell Lymphomas of Canis familiarisPLOS ONE, 2013
- Human transcriptome array for high-throughput clinical studiesProceedings of the National Academy of Sciences, 2011
- RNA sequencing shows no dosage compensation of the active X-chromosomeNature Genetics, 2010
- Analysis and design of RNA sequencing experiments for identifying isoform regulationNature Methods, 2010
- Consistency of predictive signature genes and classifiers generated using different microarray platformsThe Pharmacogenomics Journal, 2010
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive modelsNature Biotechnology, 2010
- Mapping and quantifying mammalian transcriptomes by RNA-SeqNature Methods, 2008
- The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurementsNature Biotechnology, 2006